Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TENOFOVIR DISOPROXIL vs TEPLIZUMAB-MZWV: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TENOFOVIR DISOPROXIL vs TEPLIZUMAB-MZWV: Safety Overview

Metric TENOFOVIR DISOPROXIL TEPLIZUMAB-MZWV
Total FAERS Reports 26,978 395
Deaths Reported 1,235 0
Death Rate 4.6% N/A
Hospitalizations 3,617 13
Average Patient Age 48.2 yrs 30.5 yrs
% Female Patients 31.8% 58.2%
FDA Approval Date Dec 18, 2025 N/A
Manufacturer A-S Medication Solutions N/A
Route ORAL N/A
Marketing Status Prescription Prescription